A new compound 1,3,6-tri-O-galloyl-2-O-(4-carboxylgalloyl)-β-ᴅ-glucopyranose (1), together with six known compounds (2-7) were isolated from EtOAcsoluble extract of fruits of Torreya nucifera. Their structures were elucidated on the basis of detailed spectroscopic and physico-chemical analyses. All the isolates were evaluated for in vitro inhibitory activity against PTP1B, VHR and PP1. Among them, new compound 1 was found to exhibit selective inhibitory activity on PTP1B with IC 50 value 8.9 ± 1.4 µM.
Protein tyrosine phosphatase 1B (PTP1B), a member of protein tyrosine phosphatases (PTPs), is an enzyme that catalyzes protein tyrosine dephosphorylation. It has been considered as a negative regulator of insulin signaling. Although several PTPs such as PTP-α, SH2-domain-containing phosphotyrosine phosphatase (SHP2) and leukocyte antigen-related tyrosine phosphatase (LAR) have been found to implicate in the regulation of insulin signaling, there are substantial evidences supporting that PTP1B is critical in PTPcontrolling insulin signaling pathway [1] . Published studies have demonstrated that overexpression of PTP1B inhibit the insulin receptor (IR) signaling cascade, whereas reducing the level of PTP1B could lead to the augmentation of insulin-initiated signaling [2] . Moreover, as with the insulin signaling pathway, the leptin signaling pathway can be attenuated by PTPs and PTP1B also plays a key role in this process [3] . Therefore, it has been concluded that the inhibitor of PTP1B not only could be used for the treatment of type 2 diabetes but also obesity. Based on the current situation that many anti-diabetic and anti-obesity chemical agents have some limitations and even severe adverse-effects, so making effort to discover novel PTP1B inhibitors with suitable pharmacological properties is essential.
Torreya nucifera (L.) Siebold & Zucc (Taxaceae) is a tree predominantly found in snowy areas near the Sea of Jeju Island in Korea. It has been used in Asian medicine as a remedy to treat stomachache, hemorrhoids, and rheumatoid arthritis [4] . The seed of T. nucifera showed significant insecticidal activity and its fruits not only could be used as a delicious food in Korea, but also be used to treat tapeworm infestation and atherosclerosis [5] . Previous chemical studies of T. nucifera revealed the presence of sesquiterpenoids [6] , labdane [7] and abietane diterpenoids [8] , flavonoids [5] and lignans [9] .
During the course of our search for PTP1B inhibitors from natural sources, T. nucifera was investigated. A new compound 1,3,6-tri-Ogalloyl-2-O-(4-carboxylgalloyl)-β-ᴅ-glucopyranose was isolated from EtOAc extract of the fruits of T. nucifera, along with six known compounds (2-7) (Figure 1 ). Herein, we report the isolation and structural elucidation of this new compound as well as our evaluation of their PTP1B, human vaccinia H1 related protein (VHR) and protein phosphatase 1 (PP1) inhibitory activities. 6 .63 (1H, t, J = 9.5 Hz), 6 .21 (1H, t, J = 9.5 Hz), 6 .21 (1H, m), 4.76 (2H, dd, J = 12.0, 4.0 Hz), 4.60 (1H, t, J = 9.5 Hz). The 13 C NMR spectrum (Table 1 ) of 1 revealed the presence of twenty four aromatic carbons, five carbonyl carbons [δ 167.9 (C-7''''), 167.7 (C-7''), 167.3 (C-7'''), 167.1 (C-8''), 166.6 (C-7')], and six carbons of sugar moiety [δ 94.4 (C-1), 74.9 (C-4), 74.3 (C-2), 72.7 (C-5), 69.9 (C-3), 63.5 (C-6)]. The sugar moiety in 1 was evident from 1D, 2D NMR spectral analysis and the comparison of 1,2,3,6-tetra-O-galloyl-β-ᴅ-glucopyranose [10] . The d at δ 6.81 (J = 8.0 Hz) was assigned to an anomeric H-atom of the sugar moiety. The HMBC (Figure 2 ) showed key correlations of δ 6.81 (H-1) to δ 74.3 (C-2), of δ 6.63 (H-2) to δ 69.9 (C-3), and of 6.21 (H-3) to δ 74.9 (C-4) and 74.3 (C-2), which indicated the assignment of these sugar signals. And those chemical shifts clearly suggested that all sugar hydroxyl groups were esterified except that of C-4. In addition, the coupling constants of the sugar H-atoms were very similar to those of 1,2,3,6-tetra-O-galloyl-β-ᴅ-glucopyranose. It suggested that glucopyranose core should adopt the 4 C 1 conformation and its anomeric carbon should be the β-configuration on the basis of coupling constant of the anomeric proton (J = 8.0 Hz). Moreover, the experiment of acidic hydrolysis indicated the presence of a ᴅ-glucose moiety. The HMBC spectrum showed correlations of δ 7.94 (H-2'''', 6'''') to δ 167.9 (C-7''''), of δ 7.89 (H-2', 6') to δ 166.6 (C-7'), of δ 7.87 (H-2''', 6''') to δ 167.3 (C-7'''), of δ 7.85 (H-2'', 6'') to δ 167.7 (C-7''). This led to the assignment of these four carbonyl groups to the galloyl groups. Similarly, the sugar signals at δ 6.81 (H-1), 6 .63 (H-2), 6.21 (H-3), 4.76 (H-6) were correlated to the carbonyl carbons at δ 166.6 (C-7'), 167.7 (C-7''), 167.3 (C-7'''), 167.9 (C-7''''), respectively. This confirmed that the galloyl moieties in 1 were at C-1, C-2, C-3 and C-6 of the glucose unit. Furthermore, The several differences between 1 and 1,2,3,6-tetra-O-galloyl-β-ᴅ-glucopyranose can be found in 13 C NMR data. The δ 140.2, 146.4, 146.5 of 1,2,3,6-tetra-O-galloyl-β-ᴅ-glucopyranose were replaced by δ 120.7, 159.1, 160.1 of 1 and an additional carbon at δ 167.1 (C-8'') appeared in the 13 C NMR of 1. Combined with the key HMBC correlations of δ 7.85 (H-2'', 6'') to 120.9 (C-1''), 111.4 (C-2'', 6''), 159.1 (C-3''), δ 120.7 (C-4''), 160.1 (C-5'') and 167.7 (C-7'') as well as MS data, a carboxyl group was located at C-4'' could be deduced. Perhaps because of steric effect, the value of C-3'' and C-5'' is not completely same although the structure of dihydroxyterephthalic acid moiety is symmetric. On the basis of the above data, the structure of 1 was elucidated as 1,3,6-tri-O-galloyl-2-O-(4-carboxylgalloyl)-β-ᴅ-glucopyranose. (7) based on the NMR data [10, 11] .
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All the isolates were assayed for their inhibitory activity against PTP1B. To study the selectivity of these compounds, the inhibitory activity on VHR and PP1 was also evaluated ( Table 2 ). The known inhibitor, RK-682, was used as the positive control [12] . The result of experiment showed that seven compounds inhibited PTP1B activity with IC 50 values ranging from 7.5 ± 1.2 to 31.2 ± 1.1 M in a dose-dependent manner. Among the isolates, compounds 2 (IC 50 = 7.5 ± 1.2 M) displayed high inhibitory activity on PTP1B compared with compound 3 (IC 50 = 31.2 ± 1.1 M) and 4 (IC 50 = 20.4 ± 1.3 M), which indicated that the PTP1B inhibitory activity might be associated with the galloyl moiety. The more galloyl moiety, the better inhibitory activity against PTP1B. In addition, compound 1 (IC 50 = 8.9 ± 1.4 M), which has a dihydroxyterephthalic acid group, had a higher inhibitory activity than 4 (IC 50 = 20.4 ± 1.3 M). It indicated that the presence of dihydroxyterephthalic acid group may be responsible for the increased activity. Furthermore, compound 5 (IC 50 = 15.4 ± 1.3 M) exhibited higher PTP1B inhibitory activity than compound 6 (IC 50 = 25.4 ± 1.0 M), suggesting hexahydroxydiphenoyl (HHDP) moiety might plays an important role in inhibiting PTP1B activity. Although compounds 1 and 2 exhibited significant inhibitory activity against PTP1B, there are no evidences suggesting that they have inhibitory activities on VHR and PP1. And all compounds did not have inhibitory activity toward PP1. However, compounds 3, 5, 6 showed moderate inhibitory activity on VHR and 3 (IC 50 = 22.4 ± 1.1 M) displayed high activity compared with 5 (IC 50 = 33.7 ± 1.3 M) and 6 (IC 50 = 38.6 ± 1.4 M). This result indicated that galloyl moieties might have negative effect on inhibiting activity of VHR. The investigation and optimization of hydrolysable tannin derivatives have enabled the discovery of new PTP1B inhibitor and provided the potentially therapy to treating type 2 diabetes as well as obesity.
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Experimental
General Experimental Procedures: Optical rotations were determined on a JASCO P-1020 polarimeter using a 100-mm glass microcell (JASCO, Tokyo, Japan). UV spectra were recorded in MeOH using a Shimadzu spectrometer (Shimadzu, Tokyo, Japan). IR spectra were recorded with a JASCO FT-IR 620 spectrophotometer. Nuclear magnetic resonance (NMR) spectra were obtained from a Varian Unity Inova 500 MHz spectrometer (Varian Unity Inova, Phoenix, USA) using TMS as the internal standard. Mass spectra were obtained on a QTOF2 high resolution mass spectrometer (Micromass, Wythenshawe, UK). Column chromatography was conducted using silica gel 60 (200 m particle size, Yantai Xinde Chemical Co., Ltd, Yantai, China) and RP-18 (150-63 m particle size, Merck, Darmstadt, Germany). Thin-layer chromatography precoated TLC silica gel 60 F 254 plates from Merck were used. HPLC were carried out using a Shimadzu System LC-10AD pump equipped with a model SPD-10Avp UV detector (Shimadzu, Tokyo, Japan), and an Optima Pak  C 18 column (10×250 mm, 10 m particle size, Shiseido Fine Chemicals, Tokyo, Japan).
Plant Material:
The fruits of T. nucifera were collected in Cheju Island, Republic of Korea, and authenticated by Professor Shuang Li (College of Pharmacy, Jinan University of Traditional Chinese Medicine). A voucher specimen of the plant (No. 20151216) was deposited at Dongying people's hospital, Shandong, China.
Extraction and Isolation:
The fruits of T. nucifera (10.0 kg) were extracted with MeOH at room temperature for three days and the solution was concentrated to obtain a crude extract (626.3 g). This extract was suspended in H 2 O, partitioned successively with hexane (3000 mL), EtOAc (3000 mL) and n-BuOH (3000 mL) to afford hexane (129.5 g), EtOAc (181.0 g), n-BuOH (184.7 g) and H 2 O (117.5 g) soluble fractions, respectively. A portion of the EtOAcsoluble fraction (79 g, 75% inhibition at 30.0 µg/mL) was chromatographed over a silica gel column using a gradient of CH 2 Cl 2 -MeOH (from 50:1, 30:1 to 1:1), and was separated into 9 fractions (Fr.1-Fr.9). Fr.7 [CH 2 Cl 2 -MeOH (100:1), 18.0 g, 78% inhibition at 30.0 µg/mL] was subjected to the RP-18 column (40.0 × 3.5 cm) and eluted with MeOH-H 2 O (0:10 to 10:0) to afford 10 fractions. Further purification of Fr.7.5 (2.8 g, 82% inhibition at 30.0 µg/mL) was subjected to the RP-18 column, eluted with a stepwise gradient of MeOH-H 2 O (3:7 to 6:4) to afford 12 subfractions (Fr.7.5.1-Fr.7.5.12). After which the Fr.7.5.3 (340.1 mg) was separated by HPLC, using an gradient solvent system 10%-50% MeOH in H 2 O over 70 min yielded compounds 5 (42.2 mg, t R = 45.2 min), 6 (11.3 mg, t R = 53.4 min) and 7 (12.2 mg, t R = 60.2 min). Further purification of Fr.7.5.4 (549.0 mg) via semipreparatory HPLC using a gradient solvent system of 20%-40% MeOH in H 2 O over 50 min yielded compounds 2 (45.3 mg, t R = 32.7 min), 3 (102.0 mg, t R = 34.3 min) and 4 (75.3 mg, t R = 37.2 min). Fr.7.5.5 (218.0 mg) was purified via preparative HPLC using an isocratic solvent system of 35% MeOH in H 2 O over 60 min yielded compounds 1 (35.6 mg, t R = 46.2 min). Acidic hydrolysis: A solution of compound 1 (5 mg) in MeOH (1.0 mL) containing 10% HCl (1.0 mL) was stirred at reflux for 4 h. The hydrolysate was cooled, diluted 2-fold with H 2 O, and extracted with EtOAc (3 × 2 mL). The aqueous layer was neutralized with 2 M ammonium hydroxide and a residue was obtained in vacuo. Then residue was analyzed by TLC over silica gel [n-BuOH-AcOH-H 2 O (4:1:5), upper layer; PhOH-H 2 O (4:1)] and by comparison with authentic samples. Furthermore, the residue was dissolved in pyridine (0.4 mL) containing L-cysteine methyl ester hydrochloride (2mg) and kept at 60℃ for 2 h. Next, O-Toylisothiocyanate (2 mL) was added and the mixture was heated at 60℃ for 1 h. Finally, the reaction mixture was analyzed by HPLC and a C 18 HPLC column (4.6 × 250 mm, 10 mm particle size) was used [flow, 0.8 mL/min; mobile phase, CH 3 CN-H 2 O (25:75) containing 50 mM H 3 PO 4 ]. The structure of ᴅ-glucose of 1 was deduced from comparison of the retention times of ᴅ-glucose (t R = 18.7 min), L -glucose (t R = 17.1 min) and sugar derivatives of 1 (t R = 18.5 min). Similarly, gallic acid (t R = 7.5 min) and 2,6-dihydroxyterephthalic acid (t R = 3.4 min) from EtOAc layer could also be isolated through HPLC and identified by comparison with standards. C 18 HPLC column (4.6 × 250 mm, 10mm particle size) was used [flow, 1 mL/min; mobile phase, CH 2 OH-H 2 O (30:70) containing 25 mM H 3 PO 4 , 254 nm].
PTP1B, VHR and PP1 assays:
The enzyme activity was measured using p-nitrophenyl phosphate (pNPP) as described previously [13] . Each 96 well (final volume: 100 l) was added 2 mM pNPP and PTP1B (0.05-0.1 g) in a buffer containing 50 mM citrate (pH 6.0), 0.1 M NaCl, 1 mM EDTA, and 1 mM dithiothreitol (DTT), with or without test compounds. Following incubation at 37C for 30 min, the reaction was terminated with 1 M NaOH. The amount of produced p-nitrophenol was estimated by measuring the absorbance at 405 nm. The nonenzymatic hydrolysis of 2 mM pNPP was corrected by measuring the increase in absorbance at 405 nm without PTP1B enzyme. Dual-specificity protein tyrosine phosphatase (DS-PTP) was assayed with the VHR expressed in Escherichia coli. The reaction mixture containing VHR enzyme, 2 mM pNPP, and assay buffer (50 mM succinate, 1 mM EDTA, 140 mM NaCl, and 0.05% Tween 20, pH 6.0) was incubated at 37 °C for 30 min. The reaction was terminated by 1 M NaOH, and the dephosphorylation activity was measured. For PP1 assay, PP1 was added in the assay buffer (50 mM Tris-HCl, 0.1% β-mercaptoethanol, 1 mM EDTA, 1 mM MnCl 2 , and 20 mM MgCl 2 , pH 7.6) and incubated for 30 min. The reaction was stopped by 1 M NaOH, and amount of p-nitrophenol was measured by absorbance at 405 nm [2] .
